RFP - supply of apomorphine hydrochloride, infusion pumps, dedicated pump syringes (if applicable) and associated consumables
10 May 2019
PHARMAC invites proposals for the supply of apomorphine hydrochloride in New Zealand.
PHARMAC invites proposals for the supply in New Zealand of apomorphine hydrochloride (that allows for both intermittent dosing regimens and continuous subcutaneous infusions) (Apomorphine), ambulatory infusion pumps and dedicated pump syringes (if applicable) (Infusion Pumps) and associated consumables (as described at 3(d) (ii) of the RFP document). Together, Apomorphine and Infusion Pumps are referred to as “the Pharmaceutical”.
This request for proposals (RFP) document incorporates the following schedules:
- Schedule 1 specifies the pharmaceutical for which PHARMAC is requesting proposals and sets out the background to the RFP and the types of proposals sought;
- Schedule 2 describes the process that PHARMAC expects to follow in relation to the RFP;
- Schedule 3 sets out information about the estimated size of the current subsidised market for the pharmaceutical; and
- Schedule 4 contains the RFP form in which you are to provide details of your proposal(s) [DOCX, 29 KB].
If you wish to submit a proposal, you must submit it to PHARMAC via the Government Electronic Tenders Service (GETS) (www.gets.govt.nz(external link)) no later than 4pm NZT Friday 7 June 2019 - RFx ID 21020657.
We encourage suppliers to register with GETS and subscribe to this RFP. If you have any questions about this RFP, please post these on GETS (www.gets.govt.nz(external link)).
We look forward to receiving your proposal.
Last updated: 10 May 2019